Xinbin Pan
Overview
Explore the profile of Xinbin Pan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
83
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen M, Pan X, Wang H, Yao D
Front Oncol
. 2023 Feb;
12:1054436.
PMID: 36741727
Objectives: To study the risk factors for the onset of secondary primary malignancies (SPM) and the latency between SPM and cervical cancer after radiotherapy. Methods: We selected patients with cervical...
2.
Ou T, Wei Y, Long Y, Pan X, Yao D
Int J Gen Med
. 2022 Mar;
15:2057-2073.
PMID: 35237069
Purpose: Pyroptosis has vital roles in tumorigenesis and cancer development; however, its relationship with cervical squamous cell cancer (CSCC) remains unexplored. In this study, we aimed to develop a CSCC...
3.
Wei Y, Ou T, Lu Y, Wu G, Long Y, Pan X, et al.
PeerJ
. 2020 Dec;
8:e10414.
PMID: 33282564
Background: Ovarian cancer is a highly fatal gynecological malignancy and new, more effective treatments are needed. Immunotherapy is gaining attention from researchers worldwide, although it has not proven to be...
4.
Chen K, Li L, Qu S, Pan X, Sun Y, Wan F, et al.
Aging (Albany NY)
. 2020 Nov;
12(24):25599-25613.
PMID: 33234740
Objective: This study aimed to explore the effect of silencing hTERT on the CSC-like characteristics and radioresistance of CNE-2R cells. Results: Silencing hTERT suppressed CNE-2R cell proliferation and increased the...
5.
Nong S, Pan X, Chen K, Li Y, Zhu X
Med Sci Monit
. 2020 Jun;
26:e922244.
PMID: 32541642
BACKGROUND To compare the effects of chemotherapy dose escalation on survival and prognosis of nasopharyngeal carcinoma (NPC) patients who developed bone-only metastasis. MATERIAL AND METHODS Between October 2000 to March...
6.
Jiang Y, Qu S, Pan X, Huang S, Zhu X
Sci Rep
. 2020 Jan;
10(1):861.
PMID: 31965045
The TNM staging system of NPC is the most important model for survival prediction. However, this model does not consider the biological variability of the tumor itself. This study aimed...
7.
Li K, Wang R, Huang S, Pan X, Chen H, Zhou L, et al.
Clin Lymphoma Myeloma Leuk
. 2018 Sep;
18(12):e537-e543.
PMID: 30243570
Background: Extranodal natural killer/T-cell lymphoma (ENKTL) is a rare lymphoid malignancy with diverse clinical features and prognoses. The aims of this study were to explore the pretreatment prognostic factors of...
8.
Jiang Y, Qu S, Pan X, Huang S, Zhu X
Oncotarget
. 2018 Mar;
9(11):9992-10004.
PMID: 29515785
Background: Inflammatory response markers plays an important role in tumor progression. The aim of this analysis was to evaluate whether the neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) could predict...
9.
Meng H, Zhu X, Li L, Liang Z, Li X, Pan X, et al.
Int J Mol Med
. 2017 Aug;
40(4):1152-1164.
PMID: 28849027
To date, there are no serum biomarkers available for the prediction of recurrent nasopharyngeal carcinoma (rNPC). The diagnosis of rNPC mostly depends on imaging and biopsy of diseased tissue; however,...
10.
Chen X, Zhu X, Liang Z, Li L, Qu S, Chen K, et al.
Onco Targets Ther
. 2017 Jun;
10:2909-2921.
PMID: 28652773
Purpose: Whether neoadjuvant chemotherapy (NCT) followed by concurrent chemoradiotherapy (CCRT) could improve survival in nasopharyngeal carcinoma (NPC) remains controversial especially in the era of intensity-modulated radiation therapy (IMRT), and we...